Treatment with mesenchymal stem cells normalizes cytokine storms in decompensated liver disease
Mesenchymal stem cell (MSC) therapy shows promise in mitigating cytokine storms associated with decompensated liver disease. Our analysis reveals MSC treatment normalizes inflammatory cytokine levels, offering a potential novel therapeutic strategy. Learn more about this groundbreaking research.